Lv32
320 积分 2024-07-23 加入
Adeno-associated virus vector as a platform for gene therapy delivery
17天前
已完结
Differential molecular signatures in response to CD19-CAR T cell therapy compared with conventional pharmacotherapy in systemic lupus erythematosus
30天前
已完结
BCMA-CD19 armored compound CAR T cells in systemic lupus erythematosus: extended follow-up of a phase 1 clinical trial
30天前
已完结
Single-cell profiling of immune reset in patients with refractory generalized myasthenia gravis receiving autologous CD19/BCMA CAR-T cell therapy
1个月前
已完结
Rapid receptor internalization potentiates CD7-targeted lipid nanoparticles for efficient mRNA delivery to T cells and in vivo CAR T-cell engineering
1个月前
已完结
The U.S. Food and Drug Administration’s Perspective on Chimeric Antigen Receptor T-Cell Therapies for Autoimmune and Rheumatic Conditions
1个月前
已完结
Albumin-recruiting lipid nanoparticle potentiates the safety and efficacy of mRNA vaccines by avoiding liver accumulation
2个月前
已完结
CD19 CAR T-Cell Therapy for Autoimmune Hemolytic Anemia
2个月前
已完结
Long-term safety of lentiviral or gammaretroviral gene-modified T cell therapies
2个月前
已完结
Long-term follow-up for the development of subsequent malignancies in patients treated with genetically modified IECs
2个月前
已完结
皖公网安备34019202002308
